文献

J-GLOBAL ID：201702236207147065   整理番号：17A0601499

基礎-ボーラスインスリン療法で治療された2型糖尿病患者の夜間低血糖症に対するイプラグリフロジンの予防効果: オープンラベル,単施設,パラレル,ランダム化比較試験

Preventive effect of ipragliflozin on nocturnal hypoglycemia in patients with type 2 diabetes treated with basal-bolus insulin therapy: An open-label, single-center, parallel, randomized control study

著者 (11件)： Okajima Fumitaka (Division of Endocrinology, Department of Medicine, Chiba-Hokusoh Hospital, Nippon Medical School, Chiba, Japan) ,  Okajima Fumitaka (Department of Endocrinology, Diabetes and Metabolism, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan) ,  Nagamine Tomoko (Division of Endocrinology, Department of Medicine, Chiba-Hokusoh Hospital, Nippon Medical School, Chiba, Japan) ,  Nagamine Tomoko (Department of Endocrinology, Diabetes and Metabolism, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan) ,  Nakamura Yuko (Division of Endocrinology, Department of Medicine, Chiba-Hokusoh Hospital, Nippon Medical School, Chiba, Japan) ,  Nakamura Yuko (Department of Endocrinology, Diabetes and Metabolism, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan) ,  Hattori Naomi (Division of Endocrinology, Department of Medicine, Chiba-Hokusoh Hospital, Nippon Medical School, Chiba, Japan) ,  Hattori Naomi (Department of Endocrinology, Diabetes and Metabolism, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan) ,  Sugihara Hitoshi (Department of Endocrinology, Diabetes and Metabolism, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan) ,  Emoto Naoya (Division of Endocrinology, Department of Medicine, Chiba-Hokusoh Hospital, Nippon Medical School, Chiba, Japan) ,  Emoto Naoya (Department of Endocrinology, Diabetes and Metabolism, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan)
資料名： Journal of Diabetes Investigation (Web)  (Journal of Diabetes Investigation (Web))
巻： 8  号： 3  ページ： 341-345  発行年： 2017年 
JST資料番号： U0507A  ISSN： 2040-1124  資料種別： 逐次刊行物 (A)
記事区分： 短報  発行国： アメリカ合衆国 (USA)  言語： 英語 (EN)

抄録/ポイント： ナトリウム-グルコース共輸送体2阻害剤の投与,またはナトリウ...

シソーラス用語： *薬物療法 ,...
準シソーラス用語： *ベーサルボーラスインスリン療法 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0601499&from=J-GLOBAL&jstjournalNo=U0507A") }}

著者キーワード (3件)： Basal-bolus insulin therapy ,  Nocturnal hypoglycemia ,  Sodium-glucose co-transporter 2 inhibitor

分類 (2件)： 代謝異常・栄養性疾患の治療  (GD05030F) ,  糖質代謝作用薬の臨床への応用  (GW13030B)

物質索引 (2件)： イプラグリフロジン ,  テネリグリプチン

引用文献 (18件)：

• Donner T, Munoz M. Update on insulin therapy for type 2 diabetes. J Clin Endocrinol Metab 2012; 97: 1405-1413.
• Okajima F, Emoto N, Kato K, et al. Effect of glycemic control on chylomicron metabolism and correlation between postprandial metabolism of plasma glucose and chylomicron in patients with type 2 diabetes treated with basal-bolus insulin therapy with or without Vildagliptin. J Atheroscler Thromb 2016. doi: 10.5551/jat.32409.
• Shimoda S, Iwashita S, Ichimori S, et al. Efficacy and safety of sitagliptin as add-on therapy on glycemic control and blood glucose fluctuation in Japanese type 2 diabetes subjects ongoing with multiple daily insulin injections therapy. Endocr J 2013; 60: 1207-1214.
• Rajeev SP, Cuthbertson DJ, Wilding JP. Energy balance and metabolic changes with sodium-glucose co-transporter 2 inhibition. Diabetes Obes Metab 2016; 18: 125-134.
• Zinman B, Wanner C, Lachin JM, et al. Investigators E-RO: Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med 2015; 373: 2117-2128.

タイトルに関連する用語 (14件)： 基礎 ,  ボー ,  ラス ,  インスリン療法 ,  治療 ,  2型糖尿病 ,  患者 ,  夜間低血糖症 ,  イプラグリフロジン ,  予防効果 ,  ラベル ,  施設 ,  パラレル ,  ランダム化比較試験